Literature DB >> 4554271

Mebeverine, an effective agent in the irritable colon syndrome.

P Baume.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4554271     DOI: 10.1111/j.1445-5994.1972.tb03904.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


× No keyword cloud information.
  5 in total

Review 1.  A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.

Authors:  Mahnaz Darvish-Damavandi; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

2.  A double-blind randomised, placebo-controlled trial evaluating the influence of oral long-acting muscle relaxant (Mebeverine MR), and insufflation with CO(2) on pain associated with barium enema.

Authors:  A S Lowe; A H Chapman; D Wilson; A G Culpan
Journal:  Eur Radiol       Date:  2003-01-14       Impact factor: 5.315

Review 3.  Drug treatment of the irritable bowel syndrome.

Authors:  P L Pattee; W G Thompson
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 4.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

Review 5.  The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome-A Systematic Review.

Authors:  Jaroslaw Daniluk; Ewa Malecka-Wojciesko; Barbara Skrzydlo-Radomanska; Grazyna Rydzewska
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.